CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Biontech Cell&gene Therapies's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 14, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 26, 2023Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination1
Feb 16, 2022Claudin-6-Specific Immunoreceptors And T Cell Epitopes1
Sep 2, 2020Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes1

Top competitors of Biontech Cell&gene Therapies

Top competitors of Biontech Cell&gene Therapies based on patent oppositions.